nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of...

38

Transcript of nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of...

Page 1: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 2: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 3: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 4: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 5: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 6: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 7: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 8: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 9: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 10: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 11: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 12: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 13: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 14: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 15: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 16: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 17: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 18: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 19: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 20: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 21: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 22: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 23: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 24: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 25: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 26: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 27: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 28: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 29: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 30: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 31: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 32: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 33: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 34: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 35: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 36: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 37: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous
Page 38: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous

State of the Art Therapy for HCV - University of Washingtondepts.washington.edu/hepstudy/presentations/...• Favorable clinical pharmacology profile - No food effect - No significant

State of the Art Therapy for HCV - University of Washingtondepts.washington.edu/hepstudy/presentations/...• Favorable clinical pharmacology profile - No food effect - No significant

nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/75/ribavirinduration and dose ...depts.washington.edu/hepstudy/presentations/uploads/75/... · 2014-02-18 · Treatment Duration

nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/75/ribavirinduration and dose ...depts.washington.edu/hepstudy/presentations/uploads/75/... · 2014-02-18 · Treatment Duration

Natural History of Hepatitis C Infectiondepts.washington.edu/hepstudy/presentations/... · Natural History of Hepatitis C Infection Recorded on May 15, 2013 . Slide 2 of 16 Disclosure

Natural History of Hepatitis C Infectiondepts.washington.edu/hepstudy/presentations/... · Natural History of Hepatitis C Infection Recorded on May 15, 2013 . Slide 2 of 16 Disclosure

Phase 3 - University of Washingtondepts.washington.edu/hepstudy/presentations/... · Abbreviations: DCV = daclatasvir; SOF = sofosbuvir 97 78 100 89 50 92 0 20 40 60 80 100 Treatment

Phase 3 - University of Washingtondepts.washington.edu/hepstudy/presentations/... · Abbreviations: DCV = daclatasvir; SOF = sofosbuvir 97 78 100 89 50 92 0 20 40 60 80 100 Treatment

Sofosbuvir in Genotypes 2 or 3 VALENCE Trialdepts.washington.edu/hepstudy/presentations/uploads/93/valence.pdf · Sofosbuvir and Ribavirin for HCV GT 2 or 3 VALENCE: Results for GT

Sofosbuvir in Genotypes 2 or 3 VALENCE Trialdepts.washington.edu/hepstudy/presentations/uploads/93/valence.pdf · Sofosbuvir and Ribavirin for HCV GT 2 or 3 VALENCE: Results for GT

Treatment of Chronic HCV Genotype 5 or 6depts.washington.edu/hepstudy/presentations/uploads/126/m5_l5... · • Decompensated hepatic disease • Major uncontrolled depressive illness

Treatment of Chronic HCV Genotype 5 or 6depts.washington.edu/hepstudy/presentations/uploads/126/m5_l5... · • Decompensated hepatic disease • Major uncontrolled depressive illness

Addressing Psychiatric Issues Prior to HCV Treatmentdepts.washington.edu/hepstudy/presentations/uploads/35/m4_l3... · Raison CL, Broadwell SD, Borisov AS, Manatunga AK, Capuron L,

Addressing Psychiatric Issues Prior to HCV Treatmentdepts.washington.edu/hepstudy/presentations/uploads/35/m4_l3... · Raison CL, Broadwell SD, Borisov AS, Manatunga AK, Capuron L,

Hepatitis C Testing Recommendationsdepts.washington.edu/hepstudy/presentations/... · Source: Rein, DB et al Ann Intern Med 2012:156:263-70. web study HCV Testing of Persons Born

Hepatitis C Testing Recommendationsdepts.washington.edu/hepstudy/presentations/... · Source: Rein, DB et al Ann Intern Med 2012:156:263-70. web study HCV Testing of Persons Born

Ombitasvir-Paritaprevir-Ritonavir (Techniviedepts.washington.edu/hepstudy/presentations/uploads/161/technivie... · 16/12/2015  · Ombitasvir-Paritaprevir-Ritonavir (Technivie)•

Ombitasvir-Paritaprevir-Ritonavir (Techniviedepts.washington.edu/hepstudy/presentations/uploads/161/technivie... · 16/12/2015  · Ombitasvir-Paritaprevir-Ritonavir (Technivie)•

Acute Hepatitis C Virus Infection: Epidemiology, Clinical ...depts.washington.edu/hepstudy/presentations/uploads/6/m1_l5acute_hep_c.pdfHepatitis web study HEPATITIS WEB STUDY H. Nina

Acute Hepatitis C Virus Infection: Epidemiology, Clinical ...depts.washington.edu/hepstudy/presentations/uploads/6/m1_l5acute_hep_c.pdfHepatitis web study HEPATITIS WEB STUDY H. Nina

nfs/bronfs/uwfs/hw00/d99/nwaetc/presentations/uploads/117 ...

nfs/bronfs/uwfs/hw00/d99/nwaetc/presentations/uploads/117 ...

nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/52/optimizedepts.washington.edu/hepstudy/presentations/uploads/52/optimize.p… · web study . Twice Daily Telaprevir for

nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/52/optimizedepts.washington.edu/hepstudy/presentations/uploads/52/optimize.p… · web study . Twice Daily Telaprevir for

ION-4 - University of Washingtondepts.washington.edu/hepstudy/presentations/uploads/149/ion4_ls.pdfION-4 Trial: Features ION-4 Trial Design: Open-label, single group, phase 3 trial,

ION-4 - University of Washingtondepts.washington.edu/hepstudy/presentations/uploads/149/ion4_ls.pdfION-4 Trial: Features ION-4 Trial Design: Open-label, single group, phase 3 trial,

Treatment Naïve - University of Washingtondepts.washington.edu/hepstudy/presentations/uploads/57/quest1.pdfQUEST-1 Trial QUEST-1 Trial: Features Design: Randomized, double-blind,

Treatment Naïve - University of Washingtondepts.washington.edu/hepstudy/presentations/uploads/57/quest1.pdfQUEST-1 Trial QUEST-1 Trial: Features Design: Randomized, double-blind,

nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/5 ...depts.washington.edu/hepstudy/presentations/... · Age-Adjusted Mortality Rates from HBV, HCV, & HIV United States, 1999-2007

nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/5 ...depts.washington.edu/hepstudy/presentations/... · Age-Adjusted Mortality Rates from HBV, HCV, & HIV United States, 1999-2007

Phase 3 - depts.washington.edudepts.washington.edu/hepstudy/presentations/uploads/164/ally3.pdf · Hepatitis Source: Nelson DR, et al. Hepatology 2015;61:1127-35. web study Treatment-Experienced

Phase 3 - depts.washington.edudepts.washington.edu/hepstudy/presentations/uploads/164/ally3.pdf · Hepatitis Source: Nelson DR, et al. Hepatology 2015;61:1127-35. web study Treatment-Experienced

Ombitasvir-Paritaprevir-Ritonavir + Dasabuvir Viekira …depts.washington.edu/hepstudy/presentations/uploads/131/...Hepatitis web study Ombitasvir-Paritaprevir-Ritonavir + Dasabuvir

Ombitasvir-Paritaprevir-Ritonavir + Dasabuvir Viekira …depts.washington.edu/hepstudy/presentations/uploads/131/...Hepatitis web study Ombitasvir-Paritaprevir-Ritonavir + Dasabuvir

CFOA UwFS Protocol Code of Practice v2

CFOA UwFS Protocol Code of Practice v2

Treatment Naïve and Treatment Experienceddepts.washington.edu/hepstudy/presentations/uploads/82/cosmos.pdf · Simeprevir + Sofosbuvir +/- Ribavirin in Genotype 1 COSMOS Trial Phase

Treatment Naïve and Treatment Experienceddepts.washington.edu/hepstudy/presentations/uploads/82/cosmos.pdf · Simeprevir + Sofosbuvir +/- Ribavirin in Genotype 1 COSMOS Trial Phase

Treatment of Hepatitis C in Patients with Renal Insufficiencydepts.washington.edu/hepstudy/presentations/... · Hepatitis C Treatment Issues Related to Renal Disease • Hepatitis

Treatment of Hepatitis C in Patients with Renal Insufficiencydepts.washington.edu/hepstudy/presentations/... · Hepatitis C Treatment Issues Related to Renal Disease • Hepatitis